TLDR: Colleen Hoover released her new thriller Woman Down on January 13, 2026, ending a three-year publishing hiatus. She was diagnosed with cancer in late 2025 (environmental/lifestyle causes, not genetic), completed radiation treatment on January 12, 2026, and is now in recovery.
She has three major movies releasing in 2026: Reminders of Him (March 13, which she co-wrote the screenplay for), Verity with Anne Hathaway and Dakota Johnson (October 2), and Regretting You which already made $90 million despite a 27% critic score.
However, the It Ends With Us sequel (It Starts With Us) is stuck because of a nasty legal battle between Blake Lively and Justin Baldoni, with a trial scheduled for March 9, 2026.
Woman Down is about an author who faces viral backlash over a movie adaptation, which mirrors Hoover’s real experience with the It Ends With Us drama, though she insists readers shouldn’t draw connections to her personal life.
If you haven’t checked in on Colleen Hoover lately, 2026 has been intense. A cancer diagnosis, radiation treatment, a new thriller that reads like a disguised autobiography, three movie adaptations dropping this year, and a legal battle that’s preventing the It Ends With Us sequel from happening.
The BookTok queen has been through it. But she’s also dominating. Her movies are making money regardless of what critics say, her new book is getting devoured by fans, and she’s taking creative control in ways she didn’t before.
Here’s everything happening with Colleen Hoover in 2026.
She Was Diagnosed With Cancer in Late 2025
The biggest personal news is Colleen Hoover’s health crisis. In late 2025, she was diagnosed with cancer.
The first public hint came in October 2025 when she cancelled her appearance at the Regretting You movie premiere. She cited an “unavoidable surgery” and said she couldn’t travel.
In December 2025, she confirmed to fans in a private Facebook group that the diagnosis was cancer. She’d been managing “recurring health issues” while filming the Reminders of Him adaptation in Canada but delayed treatment until production wrapped. That tells you how seriously she takes creative control of her movies.
On January 12, 2026 (the day before her new book released), Hoover posted from Texas Oncology that she was on her “second to last day of radiation.” This confirmed her treatment involved surgery and radiation but notably, she didn’t need chemotherapy.
What caused it?
Hoover shared genetic testing results to clear up rumors. It wasn’t genetic (not BRCA), not caused by HPV, not hormonal. Her doctors attributed it to “environmental/lifestyle” factors, specifically “lack of exercise, poor diet, and stress.”
She joked about hating vegetables and the gym, warning fans: “If you see me at a restaurant eating grilled chicken and drinking water, I’m probably real mad about it.” Classic Hoover, using humor to process something scary.
Because of the health crisis, there’s no full tour for Woman Down. She’s said she might do “at least one signing” but won’t know until she knows. The promotional burden has shifted almost entirely to BookTok and digital platforms.
Woman Down Is About an Author Facing Viral Backlash (Sound Familiar?)
Woman Down dropped on January 13, 2026, published by Amazon’s Montlake imprint. It’s Hoover’s first major release in three years, and it’s a psychological thriller, not a romance.
This isn’t entirely new material. The book is an expanded version of Saint, a novella she contributed to a 2020 charity anthology. The original was about 18,000 words. Woman Down is over 100,000 words (315 pages), a five-fold expansion with new subplots, character name changes, and additional twists.
The plot
Petra Rose is a bestselling author in crisis. She’s facing “viral backlash” because a beloved character was removed from a movie adaptation of her work. Fans turn on her, calling her a “fraud” and “fame-hungry opportunist.” Sound familiar?
Petra retreats to a secluded cabin to force a creative breakthrough. A detective named Nathaniel Saint shows up at her door, and he looks exactly like a character in her unwritten book. She uses him as a “real-life muse,” blurring boundaries between fiction and reality. The relationship becomes dangerous and obsessive.
The meta angle
The parallels to Hoover’s real life are obvious. The viral backlash in the book mirrors the intense, polarizing discourse around the It Ends With Us film, specifically the Blake Lively vs. Justin Baldoni feud and the internet pile-on that followed.
Hoover included an author’s note asking readers not to draw connections to her personal life, stating “there are none” and she “just wants to be a writer writing about a writer.” But come on. The thematic resonance is undeniable.
By writing about the trauma of being cancelled by your own fanbase, Hoover is processing what she’s called the “PTSD” she suffered from the film’s legal drama. It’s literary therapy disguised as a thriller.
Fan Reception Is Split
Early reviews show Hoover’s fanbase engaging but divided on the genre shift.
The fans love it!
Reviews call it “unputdownable,” “breakneck speed,” a “quick binge.” Fans of Verity embrace the darkness, calling it “quite possibly her darkest book yet.” The ending is described as a “jaw-dropping doozy.”
The friction points:
Some readers expecting traditional romantic suspense found it “darker/vulgar,” citing voyeuristic elements. There’s genre confusion, with one review warning “this is NOT a thriller!!” but romantic suspense. The cheating trope (Detective Saint is married) bothers some readers, though Hoover’s execution kept them engaged.
Critics on literary social media view the “author backlash” plot as self-indulgent or a calculated attempt to capitalize on the It Ends With Us drama. Some call it her “2025 autobiography disguised as suspense.”
But here’s the thing about Colleen Hoover. She’s critic-proof. Her fans will buy regardless of what reviewers say.
“Regretting You” Made $90 Million Despite Critics Hating It
Released October 24, 2025, Regretting You is the proof that Hoover’s movie empire is real and sustainable.
Budget: $30 million. Global gross: Over $90 million. That’s a massive profit for a mid-budget romance.
It debuted in second place but took the number one spot in its second weekend. It’s now surpassed notable films like David Fincher’s Zodiac ($83 million) in Paramount’s catalog.
The critic/audience split tells the whole story:
Rotten Tomatoes Critic Score: 27% (panned as “uninspired,” “boring,” “too long”). Rotten Tomatoes Audience Score: 85% (praised as a “toasty comfort watch”).
This is the “Colleen Hoover effect.” Her audience is completely decoupled from critical consensus. They know what they want, critics be damned.
After the theatrical run, Regretting You premiered on Paramount+ on December 23, 2025, capturing holiday viewers and driving subscription value.
“Reminders of Him” Hits Theaters March 13 (And She Co-Wrote It)
The next major release is Reminders of Him on March 13, 2026, from Universal Pictures. This one is different because Colleen Hoover co-wrote the screenplay with Lauren Levine.
This is strategic. After the It Ends With Us drama, Hoover is tightening creative control to prevent interpretive conflicts. If she writes it herself, nobody can blame her for what gets cut or changed.
The film is directed by Vanessa Caswill (Love at First Sight) leading an “all-female filmmaking team,” emphasized to appeal to the core demographic and avoid “male gaze” criticisms.
The cast: Maika Monroe as Kenna Rowan. Monroe, known for horror/thriller roles (Longlegs, It Follows), signals a grittier approach. Tyriq Withers as Ledger Ward, the male lead (bar owner, former NFL player).
Rudy Pankow (Outer Banks) plays the deceased boyfriend in flashbacks. Lauren Graham (Gilmore Girls) plays the custodial grandmother. Country star Lainey Wilson makes her feature film debut.
The story: Kenna returns to her hometown after five years in prison for a tragic mistake involving her boyfriend’s death. She’s trying to reunite with her daughter. The first trailer (released October 2025) highlighted the emotional weight, setting expectations for a tear-jerker.
“Verity” Is the Prestige Thriller (Anne Hathaway, October 2026)
Verity is the crown jewel of the 2026 slate. Releasing October 2, 2026 from Amazon MGM Studios, this positions Hoover’s IP in the high-stakes psychological thriller genre.
Originally slated for May 2026, the release was pushed to October to align with fall thriller season, mimicking Gone Girl’s strategy. Amazon MGM views this as a potential awards contender or at least a massive seasonal hit.
The cast: Anne Hathaway as Verity Crawford (also producing). Playing the villainous/ambiguous title character lets Hathaway flex her dramatic range. Dakota Johnson as Lowen Ashleigh, the struggling writer protagonist. Josh Hartnett as Jeremy Crawford, continuing his career renaissance.
Filming wrapped April 9, 2025. It’s currently in post-production.
If Verity succeeds critically (not just commercially), it legitimizes Hoover in a way romance adaptations can’t. This could be her crossover moment into “serious” Hollywood.
The “It Ends With Us” Sequel Is Stuck in Legal Hell
While new adaptations flourish, the sequel to Hoover’s biggest hit is paralyzed.
The rights to It Starts With Us are held by Wayfarer Studios, Justin Baldoni’s production company. Blake Lively reportedly refuses to work with Baldoni again. Baldoni controls the sequel rights but can’t make the movie without Lively, who is synonymous with Lily Bloom.
This created a legal nuclear war.
The lawsuit: Blake Lively sued Baldoni and Wayfarer Studios for sexual harassment and running a “smear campaign.” Baldoni countersued for defamation and extortion, alleging Lively and Ryan Reynolds conspired to seize creative control and destroy his reputation.
Trial date: March 9, 2026. A federal judge in New York set this date. The entirety of 2025 was consumed by discovery (emails, texts, production notes), which likely made reconciliation impossible.
The crisis management angle: Lively’s legal team filed to depose Jed Wallace, a crisis management specialist. Lively alleges Wallace was hired by Baldoni to orchestrate the “organic pile-on” on social media that turned public sentiment against her during the film’s release.
This allegation suggests the backlash wasn’t natural fan reaction but a manufactured weapon in a corporate war. The 2026 trial will expose the mechanics of how celebrity feuds are engineered.
And guess what? That’s exactly what happens in Woman Down. An author facing manufactured viral backlash. Hoover isn’t just processing her trauma. She’s calling out the industry machinery.
What’s Coming Next: One Good Reason and One Bad Reason
Looking beyond 2026, Hoover has started outlining her next project: two linked novels titled One Good Reason and One Bad Reason.
The plan? Release both on the same day. A “binge-drop” strategy borrowed from streaming TV. This leverages her readers’ voracious consumption habits and could monopolize bestseller charts entirely.
The books will feature overlapping stories, likely exploring the same events from opposing perspectives, similar to what she did with Maybe Now.
The 2026 Movie Schedule
Here’s the full lineup:
Reminders of Him – March 13, 2026 (Universal). Stars: Maika Monroe, Tyriq Withers. Status: Hoover co-wrote screenplay.
Verity – October 2, 2026 (Amazon MGM). Stars: Anne Hathaway, Dakota Johnson, Josh Hartnett. Status: Post-production, potential awards play.
Regretting You – Already released (October 2025), now streaming on Paramount+. Made $90M on $30M budget despite 27% critic score.
Three movies in one calendar year is unprecedented for a romance author. This is a full cinematic universe.
Why She’s Winning Despite Everything
Let’s be real. Colleen Hoover has faced:
A cancer diagnosis and radiation treatment. Viral backlash from the It Ends With Us drama. A legal battle that’s preventing her biggest sequel. Critics who consistently pan her work.
And yet she’s dominating. Why?
- She’s critic-proof. Regretting You proved her audience doesn’t care what Rotten Tomatoes says. They know what they want.
- She’s diversifying. By establishing herself in thrillers (Verity, Woman Down), she’s reducing reliance on romance and mitigating genre fatigue.
- She controls the narrative. Direct communication with fans via social media bypasses traditional media filters. She told fans about her cancer on her terms. She addressed the Woman Down connections on her terms.
- She’s taking creative control. Co-writing Reminders of Him means no more “they ruined my book” complaints. She’s learned from It Ends With Us.
- The IP is bulletproof. Even with the It Starts With Us sequel stuck, she has Verity, Reminders of Him, and a backlog of 20+ books ready for adaptation. The pipeline is endless.
The Bottom Line
As of January 2026, Colleen Hoover is at the apex of a complex media empire. She navigated a cancer diagnosis, completed treatment, and released Woman Down the day after her second-to-last radiation session. That’s dedication.
She has three major films in 2026 (Reminders in March, Verity in October, plus Regretting You still streaming). The It Ends With Us sequel is paralyzed by the Blake Lively vs. Justin Baldoni legal war, with trial in March, but that’s one franchise out of many.
Woman Down reads like her processing the viral backlash experience through fiction. She says don’t draw connections to her life, but the parallels are obvious. An author facing manufactured outrage over a movie adaptation? That’s her 2024-2025 in a nutshell.
Critics can pan her movies. The internet can turn on her. A legal battle can freeze her biggest franchise. But the “CoHo” phenomenon endures because she has a direct line to millions of readers who don’t need critics to tell them what to like.
She’s recovering from cancer, releasing books, making movies, and taking creative control.
The Piano Man might have retired, but the BookTok Queen is just getting started.
